Rosetta Capital Limited is a private equity general partner firm headquartered in London, United Kingdom.
Danish biotech Forward Pharma, backed by NB Capital, BioScience Managers and BVF Partners, is looking to raise $200m in a Nasdaq IPO.
Novimmune SA, a Swiss drug company, has raised a CHF60m Series B financing round, which was led by Rosetta Capital.
b-to-v Partners and Rosetta Capital-led investor syndicate have acquired stakes in 13 companies from Karolinska Development.
Read more news concerning Rosetta Capital Limited
A sampling of Rosetta Capital Limited portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?